Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells

Wei Zong1, Chen Yu, Ping Wang

  • 1Department of Gastroenterology, Shaanxi Provincial People's Hospital, the Third Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.

Oncology Research
|May 15, 2016
PubMed

Insights

SAM and SH3 domain-containing 1 (SASH1) suppresses gastric cancer cell invasion. SASH1 inhibits transforming growth factor (TGF)-β1-induced epithelial-mesenchymal transition (EMT) via the PI3K/Akt pathway, suggesting SASH1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Epithelial-mesenchymal transition (EMT) is crucial for gastric cancer metastasis.
  • SAM and SH3 domain-containing 1 (SASH1) is a potential tumor suppressor, but its role in gastric cancer is unclear.

Purpose of the Study:

  • To investigate the effect of SASH1 on gastric cancer cell behavior.
  • To determine SASH1's impact on transforming growth factor (TGF)-β1-induced EMT.

Main Methods:

  • Assessed SASH1 expression in gastric cancer cells.
  • Examined SASH1's effect on TGF-β1-treated gastric cancer cells (TSGH cells).
  • Analyzed cell migration, invasion, and PI3K/Akt signaling pathway activity.

Main Results:

  • SASH1 expression was low in gastric cancer cells and inhibited by TGF-β1.
  • SASH1 suppressed TGF-β1-induced EMT, cell migration, and invasion.
  • SASH1 inhibited PI3K and Akt phosphorylation in TGF-β1-stimulated cells.

Conclusions:

  • SASH1 inhibits TGF-β1-induced EMT in gastric cancer via the PI3K/Akt pathway.
  • SASH1 demonstrates potential as a therapeutic target for gastric cancer treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K